SARS-Coronavirus Envelope Protein (SARS-CoV E) (C-Term) Peptid
SARS-CoV E
Reaktivität: SARS Coronavirus (SARS-CoV)
BP
Sodium azide
-
- Target Alle SARS-Coronavirus Envelope Protein (SARS-CoV E) Produkte
- SARS-Coronavirus Envelope Protein (SARS-CoV E)
- Protein Region
- C-Term
- Spezies
- SARS Coronavirus (SARS-CoV)
- Applikation
- Blocking Peptide (BP)
- Produktmerkmale
-
11 amino acids near the carboxy terminus of SARS E protein.
Virus
-
- Applikationshinweise
- SARS envelope peptide is used for blocking the activity of the SARS envelope.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Haltbarkeit
- 12 months
-
- Target
- SARS-Coronavirus Envelope Protein (SARS-CoV E)
- Substanzklasse
- Viral Protein
- Hintergrund
- Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak. The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication.
-
Sie sind hier:
